about
The urate-lowering efficacy and safety of febuxostat in the treatment of the hyperuricemia of gout: the CONFIRMS trialSystematic Review of Metabolic Syndrome Biomarkers: A Panel for Early Detection, Management, and Risk Stratification in the West Virginian PopulationIncreased Risk of Cancer in relation to Gout: A Review of Three Prospective Cohort Studies with 50,358 SubjectsSmoking, habitual tea drinking and metabolic syndrome in elderly men living in rural community: the Tianliao old people (TOP) study 02.The prevalence of rheumatic diseases in central Greece: a population survey.Protective role of α-lipoic acid in hyperuricemia-induced endothelial dysfunction.Hyperuricemia and clustering of cardiovascular risk factors in the Chinese adult population.Relationship of serum uric Acid level and angiographic severity of coronary artery disease in male patients with acute coronary syndrome.Prevalence of hyperuricemia and its related risk factors in healthy adults from Northern and Northeastern Chinese provinces.Remote communication through solute carriers and ATP binding cassette drug transporter pathways: an update on the remote sensing and signaling hypothesis.The use of serum uric acid concentration as an indicator of laparoscopic sleeve gastrectomy success.Utilization of dietary glucose in the metabolic syndromeSugar-sweetened soda consumption, hyperuricemia, and kidney disease.Association of thyroid hormones with obesity and metabolic syndrome in Japanese children.Response to dietary oxalate after bariatric surgery.Comorbidities in patients with gout prior to and following diagnosis: case-control study.Serum uric acid and appropriate cutoff value for prediction of metabolic syndrome among Chinese adults.Bidirectional Association between Diabetes and Gout: the Singapore Chinese Health Study.Comorbidity Burden in Trial-Aligned Patients with Established Gout in Germany, UK, US, and France: a Retrospective Analysis.Febuxostat: a new treatment for hyperuricaemia in gout.Treating to target: a strategy to cure gout.The relationship between serum uric acid level and metabolic syndrome: differences by sex and age in Taiwanese.Inflammation, oxidative stress and lipids: the risk triad for atherosclerosis in gout.Dietary management of the metabolic syndrome - one size fits all?Systematic review of the prevalence of gout and hyperuricaemia in Australia.Genomic medicine and risk prediction across the disease spectrum.Chronic Urticaria and the Metabolic Syndrome: a Cross-sectional Community-based Study of 11,261 Patients.Hyperuricemia, the kidneys, and the spectrum of associated diseases: a narrative review.Association Between Gout and Aortic Stenosis.Association of serum uric acid with high-sensitivity C-reactive protein in postmenopausal women.Uric acid increases fibronectin synthesis through upregulation of lysyl oxidase expression in rat renal tubular epithelial cells.Impact of gout on the risk of atrial fibrillation.Potassium oxonate induces acute hyperuricemia in the tree shrew (tupaia belangeri chinensis).Gout and risk of non-alcoholic fatty liver disease.Montmorillonite adsorbs uric acid and increases the excretion of uric acid from the intestinal tract in mice.Gout: an independent risk factor for all-cause and cardiovascular mortality.As compared to allopurinol, urate-lowering therapy with febuxostat has superior effects on oxidative stress and pulse wave velocity in patients with severe chronic tophaceous gout.Invariant Natural Killer T Cells Ameliorate Monosodium Urate Crystal-Induced Gouty Inflammation in Mice.Fructose metabolism and metabolic disease.Relationship between serum uric acid levels and metabolic syndrome in Chinese postmenopausal women.
P2860
Q21195361-0876A02F-86A7-44E6-8388-B4F1A7AF9A98Q26774109-EC78E694-F0B3-4B48-B7E5-4676E1023F7AQ26778704-195D5671-1E22-485F-A609-6933AB8EBC4CQ31068053-80AE0CEF-AFB3-4451-804C-69313B4F2379Q33588016-EBF7C665-8ECF-4DA9-924F-5362BD777BFDQ33744192-664AAB34-D3C0-4676-B4AB-ED2180475B6CQ33905585-87A35AC8-AF9F-4DDF-99A0-D5D0124F288BQ34658500-183328B1-BE5C-4319-BFF3-66B0F3D9BDB1Q34834152-01DB27CE-2032-48AB-A306-F302E3A7D5D6Q34865706-2E8D6BF4-2C40-41D0-AA49-FE26DDDA4BC0Q34993211-20932E95-41DB-4E4E-981D-DB5119746F96Q35576565-9990E0E6-7638-404E-B7D4-3FF9CE32B1DCQ35820430-EB5F6679-6A29-448A-8F9A-3FDF167ABF2CQ36049100-7AAD1F76-02D9-4BB7-B1A4-C2FB0B454BE6Q36443214-458EA9A3-A494-42A8-8E69-B07A866A0FAAQ36475590-A7F75803-70F6-40AF-A58A-0691D31DD481Q36521917-E8475C00-FF52-4D32-90BF-7AFA8F3784C6Q36886192-36C2ABFF-65C0-4D37-AF9E-F0C5B7668595Q37080656-F4A68468-ED6C-48C7-B4AE-5AB6AF63DEEBQ37485326-D5C9E89E-7573-4029-9B2E-37A4AEC12C11Q37485337-6F0AC342-60B3-4397-8CE7-057B95985C4FQ37511329-56D545C5-FA9F-46B8-805B-753FA380CC03Q37702650-B455B278-0DD1-4401-B0B2-84C1F61A4D41Q38108902-F9D02C4B-576C-421A-AE54-7AF7D5194FB0Q38135856-72F1F325-5091-4D98-872F-943674DF8967Q38322338-0EC094BE-38CB-4DF8-AC03-70E0C78B8DD8Q38605883-F8EDFADB-D1E9-482D-A7FF-F934CF02EB00Q38810539-60E68DE4-C759-4A3F-9537-EE26369E835EQ38976582-1E9522EE-F8CA-4061-BFEC-49DC73AD5FB0Q39377199-58FB05F2-26F8-46A4-8538-3FCE256151EAQ39702401-0B53A68E-4964-42AC-B012-895B07F91107Q40195623-A3B8CBD7-9433-4A19-A761-EC755E49BB16Q41244910-E5D77ED1-63B2-4258-BFBA-E492CBC5484EQ43013064-718AAB00-51D8-40E4-8D05-244E31FB59C9Q43244898-D52A02E3-1981-457A-9CCC-AB05EAB5305AQ43733011-900EBA72-ED29-447B-8B2C-EE6A154A5591Q45823744-C871DD49-028A-41D4-8388-D0129D2D1FF0Q49385135-EAF9212C-E1EE-46D7-B20D-0E26711AC043Q49498180-0F9111B4-C9F8-4C63-91FB-450C62F0E0DBQ50879647-04A9DF0C-BA37-4AA0-903D-32BFBE0D43E2
P2860
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on March 2008
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Hyperuricemia, gout and the metabolic syndrome.
@en
Hyperuricemia, gout and the metabolic syndrome.
@nl
type
label
Hyperuricemia, gout and the metabolic syndrome.
@en
Hyperuricemia, gout and the metabolic syndrome.
@nl
prefLabel
Hyperuricemia, gout and the metabolic syndrome.
@en
Hyperuricemia, gout and the metabolic syndrome.
@nl
P1476
Hyperuricemia, gout and the metabolic syndrome.
@en
P2093
Juan García Puig
María Angeles Martínez
P304
P356
10.1097/BOR.0B013E3282F4B1ED
P577
2008-03-01T00:00:00Z